Ono Pharmaceutical Co., Ltd.

TSE:4528 Voorraadrapport

Marktkapitalisatie: JP¥919.7b

Ono Pharmaceutical Beheer

Beheer criteriumcontroles 3/4

Ono Pharmaceutical's CEO is Gyo Sagara, appointed in Sep 2008, has a tenure of 16.17 years. total yearly compensation is ¥190.00M, comprised of 41.1% salary and 58.9% bonuses, including company stock and options. directly owns 0.026% of the company’s shares, worth ¥234.98M. The average tenure of the management team and the board of directors is 1.8 years and 4.4 years respectively.

Belangrijke informatie

Gyo Sagara

Algemeen directeur

JP¥190.0m

Totale compensatie

Percentage CEO-salaris41.1%
Dienstverband CEO16.2yrs
Eigendom CEO0.03%
Management gemiddelde ambtstermijn1.8yrs
Gemiddelde ambtstermijn bestuur4.4yrs

Recente managementupdates

Recent updates

Ono Pharmaceutical Co., Ltd. Beat Analyst Estimates: See What The Consensus Is Forecasting For This Year

Nov 03
Ono Pharmaceutical Co., Ltd. Beat Analyst Estimates: See What The Consensus Is Forecasting For This Year

We Think Ono Pharmaceutical (TSE:4528) Can Stay On Top Of Its Debt

Aug 25
We Think Ono Pharmaceutical (TSE:4528) Can Stay On Top Of Its Debt

Ono Pharmaceutical Co., Ltd. (TSE:4528) First-Quarter Results Just Came Out: Here's What Analysts Are Forecasting For This Year

Aug 04
Ono Pharmaceutical Co., Ltd. (TSE:4528) First-Quarter Results Just Came Out: Here's What Analysts Are Forecasting For This Year

There's No Escaping Ono Pharmaceutical Co., Ltd.'s (TSE:4528) Muted Earnings

Jun 24
There's No Escaping Ono Pharmaceutical Co., Ltd.'s (TSE:4528) Muted Earnings

Ono Pharmaceutical (TSE:4528) Has Announced A Dividend Of ¥40.00

Mar 04
Ono Pharmaceutical (TSE:4528) Has Announced A Dividend Of ¥40.00

Is There An Opportunity With Ono Pharmaceutical Co., Ltd.'s (TSE:4528) 42% Undervaluation?

Feb 27
Is There An Opportunity With Ono Pharmaceutical Co., Ltd.'s (TSE:4528) 42% Undervaluation?

Analyse CEO-vergoeding

Hoe is Gyo Sagara's beloning veranderd ten opzichte van Ono Pharmaceutical's winst?
DatumTotale vergoedingSalarisBedrijfswinsten
Sep 30 2024n/an/a

JP¥95b

Jun 30 2024n/an/a

JP¥121b

Mar 31 2024JP¥190mJP¥78m

JP¥128b

Dec 31 2023n/an/a

JP¥128b

Sep 30 2023n/an/a

JP¥125b

Jun 30 2023n/an/a

JP¥115b

Mar 31 2023JP¥228mJP¥77m

JP¥113b

Compensatie versus markt: Gyo's total compensation ($USD1.24M) is about average for companies of similar size in the JP market ($USD1.08M).

Compensatie versus inkomsten: Gyo's compensation has been consistent with company performance over the past year.

CEO

Gyo Sagara (66 yo)

16.2yrs

Tenure

JP¥190,000,000

Compensatie

Mr. Gyo Sagara has been the Chief Executive Officer at Ono Pharmaceutical Co., Ltd since April 01, 2024 and serves as it’s Director and served as its President since September 2008 until April 01, 2024 and...

Leiderschapsteam

NaamPositieTenureCompensatieEigendom
Gyo Sagara
CEO & Chairman of the Board16.2yrsJP¥190.00m0.026%
¥ 235.0m
Toichi Takino
Presidentless than a yeargeen gegevens0.0092%
¥ 84.2m
Masaki Ito
Corp. Offcr. and Div. Dir. of Corp. Strategy & Planning1.3yrsgeen gegevensgeen gegevens
Takehiro Yamada
Corporate Officer & Head of Risk and Compliance Management Department1.8yrsgeen gegevensgeen gegevens
Satoshi Takahagi
Managing Executive Officerno datageen gegevensgeen gegevens
Masayuki Tanigawa
Corporate Officer & Head of Business Strategy Headquarters1.8yrsgeen gegevensgeen gegevens
Toshihiro Tsujinaka
Ex. EO, Executive Dir. of Sus. Promotion Corp. Strategy & Planning and Representative Director1.8yrsgeen gegevens0.0060%
¥ 54.8m
Hiromu Habashita
Corporate Officer & Deputy Executive Directorno datageen gegevensgeen gegevens
Shinji Takai
Corporate Officer & Head of Medical Affairsno datageen gegevensgeen gegevens
Akira Takada
Managing Executive Officer & CMC / Production Division Chiefno datageen gegevensgeen gegevens
Tatsuya Okamoto
Head of Development Div.no datageen gegevensgeen gegevens

1.8yrs

Gemiddelde duur

60yo

Gemiddelde leeftijd

Ervaren management: 4528's management team is not considered experienced ( 1.8 years average tenure), which suggests a new team.

Bestuursleden

NaamPositieTenureCompensatieEigendom
Gyo Sagara
CEO & Chairman of the Board18.4yrsJP¥190.00m0.026%
¥ 235.0m
Toichi Takino
President4.4yrsgeen gegevens0.0092%
¥ 84.2m
Toshihiro Tsujinaka
Ex. EO, Executive Dir. of Sus. Promotion Corp. Strategy & Planning and Representative Director4.4yrsgeen gegevens0.0060%
¥ 54.8m
Shusaku Nagae
Independent Outside Director3.4yrsgeen gegevensgeen gegevens
Akiko Tanabe
Outside Audit & Supervisory Board Member4.4yrsgeen gegevensgeen gegevens
Yasuo Hishiyama
Outside Audit & Supervisory Board Member8.4yrsgeen gegevensgeen gegevens
Kiyoaki Idemitsu
Audit & Supervisory Board Memberless than a yeargeen gegevens0.0032%
¥ 29.3m
Masao Nomura
Independent Outside Director6.4yrsgeen gegevensgeen gegevens
Akiko Okuno
Independent Outside Director4.4yrsgeen gegevensgeen gegevens
Hironobu Tanisaka
Chairman of Audit Supervisory Board3.4yrsgeen gegevens0.00043%
¥ 4.0m

4.4yrs

Gemiddelde duur

60yo

Gemiddelde leeftijd

Ervaren bestuur: 4528's board of directors are considered experienced (4.4 years average tenure).